CULLINAN MICA CORP.

Profile

Company Names

CULLINAN MICA CORP.

Addresses

ONE MAIN STREET, SUITE 520, CAMBRIDGE, MA 02142

11099 NORTH TORREY PINES ROAD, SUITE 290, LA JOLLA, CA 92037

Phone Numbers

617-410-4650
858-750-4700

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$26,588,638.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2022-03-10 
$10,000,000.00 
$10,000,000.00 
$0.00 
Equity 
1
2020-05-28 
$16,588,638.00 
$34,588,641.00 
$18,000,003.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
NADIM 
 
AHMED 
EXECUTIVE OFFICER, DIRECTOR
NYC GREEN TRANSPORTATION GROUP, LLC   |  CULLINAN MICA CORP.   |  NYC EV MOBILITY LLC
NEIL 
W. 
GIBSON, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
CULLINAN MICA CORP.
OWEN 
 
HUGHES 
DIRECTOR
RANA THERAPEUTICS, INC.   |  TRANSLATE BIO, INC.   |  CULLINAN MICA CORP.   |  REMEDY PLAN, INC.   |  IKENA ONCOLOGY, INC.   |  STIPPLE BIO, INC.
MORANA 
 
JOVAN-EMBIRICOS 
DIRECTOR
CLINICAL INK, INC.   |  ALLOVIR, INC.   |  CULLINAN MICA CORP.   |  ORNA THERAPEUTICS HOLDINGS, LLC   |  F2 CAPITAL I 2023 LLC
JAY 
B. 
LICHTER 
DIRECTOR
AFRAXIS, INC.   |  ZACHARON PHARMACEUTICALS INC.   |  AVALON VENTURES IX, L.P.   |  AVALON VENTURES X, L.P.   |  CULLINAN MICA CORP.
ASHER 
 
PAGE 
EXECUTIVE OFFICER
CULLINAN MICA CORP.
ANTHONY 
 
ROSENBERG 
DIRECTOR
IDENIX PHARMACEUTICALS INC   |  SIO2 MEDICAL PRODUCTS, INC.   |  CULLINAN MICA CORP.
LEIGH 
 
ZAWEL 
EXECUTIVE OFFICER
CULLINAN MICA CORP.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-03-21
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-03-10 
2020-06-10
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-05-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#